BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26269582)

  • 1. Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling.
    Archibald A; Al-Masri M; Liew-Spilger A; McCaffrey L
    Mol Biol Cell; 2015 Oct; 26(20):3578-95. PubMed ID: 26269582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
    Mana-Capelli S; McCollum D
    J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis.
    Yi C; Shen Z; Stemmer-Rachamimov A; Dawany N; Troutman S; Showe LC; Liu Q; Shimono A; Sudol M; Holmgren L; Stanger BZ; Kissil JL
    Sci Signal; 2013 Sep; 6(291):ra77. PubMed ID: 24003254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein.
    Zhao B; Li L; Lu Q; Wang LH; Liu CY; Lei Q; Guan KL
    Genes Dev; 2011 Jan; 25(1):51-63. PubMed ID: 21205866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiomotin regulates prostate cancer cell proliferation by signaling through the Hippo-YAP pathway.
    Zeng H; Ortiz A; Shen PF; Cheng CJ; Lee YC; Yu G; Lin SC; Creighton CJ; Yu-Lee LY; Lin SH
    Oncotarget; 2017 Feb; 8(6):10145-10160. PubMed ID: 28052036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
    Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
    Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actin-binding and cell proliferation activities of angiomotin family members are regulated by Hippo pathway-mediated phosphorylation.
    Chan SW; Lim CJ; Guo F; Tan I; Leung T; Hong W
    J Biol Chem; 2013 Dec; 288(52):37296-307. PubMed ID: 24225952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIBRA suppresses apical exocytosis through inhibition of aPKC kinase activity in epithelial cells.
    Yoshihama Y; Sasaki K; Horikoshi Y; Suzuki A; Ohtsuka T; Hakuno F; Takahashi S; Ohno S; Chida K
    Curr Biol; 2011 Apr; 21(8):705-11. PubMed ID: 21497093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.
    Wang J; Wang H; Zhang Y; Zhen N; Zhang L; Qiao Y; Weng W; Liu X; Ma L; Xiao W; Yu W; Chu Q; Pan Q; Sun F
    Cell Signal; 2014 May; 26(5):1048-59. PubMed ID: 24468535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of Par3 promotes prostate cancer metastasis by forming a Par3/aPKC/KIBRA complex and inactivating the hippo pathway.
    Zhou PJ; Xue W; Peng J; Wang Y; Wei L; Yang Z; Zhu HH; Fang YX; Gao WQ
    J Exp Clin Cancer Res; 2017 Oct; 36(1):139. PubMed ID: 29017577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Par3 controls epithelial spindle orientation by aPKC-mediated phosphorylation of apical Pins.
    Hao Y; Du Q; Chen X; Zheng Z; Balsbaugh JL; Maitra S; Shabanowitz J; Hunt DF; Macara IG
    Curr Biol; 2010 Oct; 20(20):1809-18. PubMed ID: 20933426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hippo component YAP localizes in the nucleus of human papilloma virus positive oropharyngeal squamous cell carcinoma.
    Alzahrani F; Clattenburg L; Muruganandan S; Bullock M; MacIsaac K; Wigerius M; Williams BA; Graham ME; Rigby MH; Trites JR; Taylor SM; Sinal CJ; Fawcett JP; Hart RD
    J Otolaryngol Head Neck Surg; 2017 Feb; 46(1):15. PubMed ID: 28222762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polarity proteins PAR6 and aPKC regulate cell death through GSK-3beta in 3D epithelial morphogenesis.
    Kim M; Datta A; Brakeman P; Yu W; Mostov KE
    J Cell Sci; 2007 Jul; 120(Pt 14):2309-17. PubMed ID: 17606986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Par-aPKC-dependent and -independent mechanisms cooperatively control cell polarity, Hippo signaling, and cell positioning in 16-cell stage mouse embryos.
    Hirate Y; Hirahara S; Inoue K; Kiyonari H; Niwa H; Sasaki H
    Dev Growth Differ; 2015 Oct; 57(8):544-56. PubMed ID: 26450797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms.
    Grzeschik NA; Parsons LM; Allott ML; Harvey KF; Richardson HE
    Curr Biol; 2010 Apr; 20(7):573-81. PubMed ID: 20362447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.
    Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
    Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
    Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of localization and function of the transcriptional co-activator YAP by angiomotin.
    Moleirinho S; Hoxha S; Mandati V; Curtale G; Troutman S; Ehmer U; Kissil JL
    Elife; 2017 May; 6():. PubMed ID: 28464980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiomotin decreases lung cancer progression by sequestering oncogenic YAP/TAZ and decreasing Cyr61 expression.
    Hsu YL; Hung JY; Chou SH; Huang MS; Tsai MJ; Lin YS; Chiang SY; Ho YW; Wu CY; Kuo PL
    Oncogene; 2015 Jul; 34(31):4056-68. PubMed ID: 25381822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.